Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATALIZUMAB-SZTN for Multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 142 adverse event reports in the FDA FAERS database where NATALIZUMAB-SZTN was used for Multiple sclerosis.

Most Reported Side Effects for NATALIZUMAB-SZTN

Side Effect Reports % Deaths Hosp.
Fatigue 63 33.5% 0 3
Mobility decreased 52 27.7% 0 0
Balance disorder 31 16.5% 0 2
Headache 18 9.6% 0 3
Product substitution issue 17 9.0% 2 3
Multiple sclerosis relapse 16 8.5% 0 1
Muscular weakness 16 8.5% 0 0
Cognitive disorder 13 6.9% 0 0
Gait disturbance 13 6.9% 0 0
Dizziness 11 5.9% 0 1
Nausea 9 4.8% 0 0
Urinary incontinence 9 4.8% 0 0
Arthralgia 7 3.7% 0 2
Dysphagia 7 3.7% 0 0
Musculoskeletal stiffness 7 3.7% 0 2

Other Indications for NATALIZUMAB-SZTN

Product used for unknown indication (33) Relapsing-remitting multiple sclerosis (10)

Other Drugs Used for Multiple sclerosis

DIMETHYL (78,567) NATALIZUMAB (56,733) INTERFERON BETA-1A (56,475) FINGOLIMOD (43,123) TERIFLUNOMIDE (29,963) DALFAMPRIDINE (28,787) GLATIRAMER (27,144) OCRELIZUMAB (15,501) OFATUMUMAB (11,816) PEGINTERFERON BETA-1A (11,105)

Related Pages

NATALIZUMAB-SZTN Full Profile All Multiple sclerosis Drugs NATALIZUMAB-SZTN Demographics NATALIZUMAB-SZTN Timeline